Petpal Pet Nutrition Technology Co., Ltd. (SHE:300673)
17.33
-0.13 (-0.74%)
At close: Feb 13, 2026
SHE:300673 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,412 | 1,645 | 1,400 | 1,726 | 1,267 | 1,313 |
Other Revenue | 13.68 | 13.68 | 11.46 | 5.56 | 3.75 | 27.21 |
| 1,425 | 1,659 | 1,411 | 1,732 | 1,271 | 1,340 | |
Revenue Growth (YoY) | -21.59% | 17.55% | -18.51% | 36.27% | -5.15% | 32.88% |
Cost of Revenue | 961.49 | 1,174 | 1,140 | 1,349 | 986.73 | 1,003 |
Gross Profit | 463.73 | 485.03 | 271.36 | 382.99 | 284.16 | 337.2 |
Selling, General & Admin | 250.61 | 232.57 | 211.56 | 205.28 | 157.33 | 141.26 |
Research & Development | 31.59 | 29.76 | 29.04 | 28.81 | 22.66 | 26.17 |
Other Operating Expenses | 7.35 | 5.26 | 5.27 | 4.33 | 4.19 | -4.06 |
Operating Expenses | 290.56 | 267.22 | 250.5 | 236.91 | 182.92 | 166.97 |
Operating Income | 173.17 | 217.8 | 20.86 | 146.08 | 101.24 | 170.23 |
Interest Expense | -23.5 | -20.4 | -20.51 | -21.66 | -8.43 | -7.89 |
Interest & Investment Income | 3.96 | 11.78 | 10 | 3.26 | 6.95 | 1.39 |
Currency Exchange Gain (Loss) | 18.58 | 18.58 | 8.15 | 52.84 | -22.57 | -23.68 |
Other Non Operating Income (Expenses) | 9.6 | -2.2 | -2.45 | -2.07 | -1.05 | -2.38 |
EBT Excluding Unusual Items | 181.82 | 225.56 | 16.06 | 178.44 | 76.15 | 137.68 |
Impairment of Goodwill | -2.15 | -2.15 | -4.37 | -1.54 | - | -2.12 |
Gain (Loss) on Sale of Investments | -0.53 | 0.99 | 0.12 | -10.75 | 0.4 | -0.17 |
Gain (Loss) on Sale of Assets | 0 | 0.02 | -9.95 | 0.06 | 0.12 | -0.01 |
Asset Writedown | -0.05 | -0.05 | -0.13 | -2.28 | -0.07 | -0.18 |
Other Unusual Items | -0.72 | -0.73 | 0.99 | 1.85 | 1.17 | -0.76 |
Pretax Income | 178.37 | 223.64 | 2.7 | 165.79 | 77.77 | 134.44 |
Income Tax Expense | 34.12 | 37.75 | 18.67 | 36.5 | 15.72 | 17.86 |
Earnings From Continuing Operations | 144.25 | 185.89 | -15.97 | 129.29 | 62.06 | 116.58 |
Minority Interest in Earnings | -3.25 | -3.68 | 4.88 | -2.16 | -2.04 | -1.76 |
Net Income | 141 | 182.21 | -11.09 | 127.12 | 60.02 | 114.83 |
Net Income to Common | 141 | 182.21 | -11.09 | 127.12 | 60.02 | 114.83 |
Net Income Growth | -18.43% | - | - | 111.81% | -47.73% | 129.62% |
Shares Outstanding (Basic) | 244 | 243 | 277 | 249 | 214 | 250 |
Shares Outstanding (Diluted) | 269 | 268 | 277 | 296 | 214 | 250 |
Shares Change (YoY) | -4.67% | -3.36% | -6.21% | 37.92% | -14.13% | 13.16% |
EPS (Basic) | 0.58 | 0.75 | -0.04 | 0.51 | 0.28 | 0.46 |
EPS (Diluted) | 0.52 | 0.68 | -0.04 | 0.43 | 0.28 | 0.46 |
EPS Growth | -14.44% | - | - | 53.57% | -39.13% | 102.91% |
Free Cash Flow | 219.33 | 239.7 | 36.49 | 74.4 | -245.88 | -226.94 |
Free Cash Flow Per Share | 0.82 | 0.90 | 0.13 | 0.25 | -1.15 | -0.91 |
Dividend Per Share | 0.350 | 0.350 | - | - | 0.030 | 0.067 |
Dividend Growth | - | - | - | - | -55.02% | - |
Gross Margin | 32.54% | 29.23% | 19.23% | 22.12% | 22.36% | 25.17% |
Operating Margin | 12.15% | 13.13% | 1.48% | 8.43% | 7.97% | 12.71% |
Profit Margin | 9.89% | 10.98% | -0.79% | 7.34% | 4.72% | 8.57% |
Free Cash Flow Margin | 15.39% | 14.45% | 2.58% | 4.30% | -19.35% | -16.94% |
EBITDA | 238.81 | 279.49 | 77.27 | 196.12 | 142.29 | 198.83 |
EBITDA Margin | 16.76% | 16.85% | 5.47% | 11.33% | 11.20% | 14.84% |
D&A For EBITDA | 65.64 | 61.68 | 56.4 | 50.05 | 41.04 | 28.6 |
EBIT | 173.17 | 217.8 | 20.86 | 146.08 | 101.24 | 170.23 |
EBIT Margin | 12.15% | 13.13% | 1.48% | 8.43% | 7.97% | 12.71% |
Effective Tax Rate | 19.13% | 16.88% | 690.78% | 22.02% | 20.21% | 13.28% |
Revenue as Reported | 1,425 | 1,659 | 1,411 | 1,732 | 1,271 | 1,340 |
Advertising Expenses | - | 62.5 | 53.94 | 43.68 | 23.74 | 29.13 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.